Taylor D A, Silvestry S C, Bishop S P, Annex B H, Lilly R E, Glower D D, Kraus W E
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Proc Assoc Am Physicians. 1997 May;109(3):245-53.
Myocardial repair after injury is limited because the adult heart cannot regenerate. We propose using autologous skeletal muscle cells (myoblasts) as a source of reserve cells for repair of regions of damaged myocardium. This report examines two potential methods for the transfer of cells to the myocardium: selective coronary catheterization, and myoblast infusion or myoblast injection directly into the left ventricular wall. Autologous, primary rabbit skeletal myoblasts were harvested, were transduced ex vivo with adenoviruses expressing the Escherichia coli beta-galactosidase (beta-gal) gene, and were infused selectively into the coronary circulation or injected directly into the myocardial wall. After either delivery method, beta-gal expression was detectable at the earliest times examined (3 days) and persisted for several weeks. The method of delivery influenced the spatial pattern of beta-gal expression. After direct injection, a localized concentration of myoblasts that decreased with distance from the injection site was visible primarily in the myocardial layer of the ventricle, although occasional staining could be detected in other layers. After coronary infusion, discrete punctate or linear foci of beta-gal expression were found throughout the distribution of the left coronary circulation in all cardiac layers. After infusion or injection, beta-gal-positive cells were seen in direct physical apposition to cardiocytes; interestingly, beta-gal could be detected also in some branched cells with clear cross-striations. Autologous myoblasts survived with no obvious dysrhythmic effects despite their presence in extensive or discrete loci in the myocardium. These observations provide the first evidence that myoblast transfer is possible by catheter-based methods, and they create the basis for studies to investigate the functional consequences of myoblast infusion in damaged heart.
由于成年心脏无法再生,损伤后的心肌修复受到限制。我们提议使用自体骨骼肌细胞(成肌细胞)作为储备细胞来源,用于修复受损心肌区域。本报告研究了两种将细胞转移至心肌的潜在方法:选择性冠状动脉导管插入术,以及将成肌细胞注入或直接注射到左心室壁。采集自体原代兔骨骼肌成肌细胞,在体外使用表达大肠杆菌β-半乳糖苷酶(β-gal)基因的腺病毒进行转导,然后选择性地注入冠状动脉循环或直接注射到心肌壁。无论采用哪种递送方法,在最早检测的时间点(3天)即可检测到β-gal表达,且持续数周。递送方法影响β-gal表达的空间模式。直接注射后,主要在心室心肌层可见成肌细胞的局部聚集,其浓度随距注射部位距离的增加而降低,尽管偶尔在其他层也可检测到染色。冠状动脉灌注后,在所有心脏层的左冠状动脉循环分布区域均发现离散的点状或线性β-gal表达灶。灌注或注射后,可见β-gal阳性细胞与心肌细胞直接物理毗邻;有趣的是,在一些具有明显横纹的分支细胞中也可检测到β-gal。尽管自体成肌细胞存在于心肌的广泛或离散位点,但它们存活下来且未产生明显的心律失常效应。这些观察结果首次证明通过基于导管的方法进行成肌细胞转移是可行的,并为研究成肌细胞灌注对受损心脏功能影响的研究奠定了基础。